ArticleOncology letters2015

Re-administration of gefitinib following diffuse interstitial lung disease in a patient with advanced lung adenocarcinoma: A case report and review of the literature.

Xueli Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.